December 13, 2024

Obstructive Sleep Apnea Affects nAMD

The potential overnight reduction of the critical oxygen supply could present a retinal health risk.

Conexiant

December 12, 2024

Melanoma Recurrence Signs with ATLAS Guide

Conexiant

December 12, 2024

54 Novel Drugs Await FDA Review

An analysis published in the American Journal of Health-System Pharmacy provides an overview of the potential next wave of pharmaceuticals.

Conexiant

December 11, 2024

Do E-Cigarettes Aid Long-Term Smoking Cessation?

Conexiant

December 11, 2024

Vitamin D Tied to ICU Survival

Conexiant

December 10, 2024

Remove Tonsils, Raise Mental Health Risk?

Conexiant

December 09, 2024

Do SGLT2i, GLP-1 RAs Cut Pneumonia, Sepsis Risk?

In the largest real-world study to date, GLP-1 receptor agonists reduced pneumonia risk by 40% in type 2 diabetes patients.

Conexiant

December 06, 2024

COPD Treatment Patterns and Exacerbations: A 4-Year Study

Conexiant

December 06, 2024

Long COVID’s Variable 24-Month Impact in Children and Adolescents

Study finds that nearly 1 in 4 children aged 11 to 17 experienced at least 3 symptoms 24 months after testing positive for COVID.

Conexiant